CARDIOMEMS HF PRESSURE MEASUREMENT SYSTEM
ABBOTT MEDICAL · Decision date May 28, 2014
What did the FDA approve?
The May 28, 2014 approval covers the CardioMEMS HF System, including the CM2000 implantable pulmonary artery sensor/monitor and transvenous catheter delivery system, the CM1000 and CM1010 patient electronics systems, and the CM3000 hospital electronics system. The stated indication is wireless measurement and monitoring of pulmonary artery pressure and heart rate in NYHA Class III heart failure patients hospitalized for heart failure in the previous year.
The approval statement says hemodynamic data are used by physicians for heart failure management with the goal of reducing heart failure hospitalizations. This reported purpose is distinct from independent proof of safety or clinical effectiveness. The statement does not include supplement type or reason, so no relationship to a prior PMA is established.
FDA approval order statement
APPROVAL FOR THE CARDIOMEMS HF SYSTEM, WHICH INCLUDES THE CM2000 IMPLANTABLE PA SENSOR/MONITOR AND TRANSVENOUS CATHETER DELIVERY SYSTEM, THE CM1000 PATIENT ELECTRONICS SYSTEM (GSM), THECM1010 PATIENT ELECTRONICS SYSTEM (GSM), AND CM3000 HOSPITAL ELECTRONICS SYSTEM. THIS DEVICE IS INDICATED FOR WIRELESSLY MEASURING AND MONITORING PULMONARY ARTERY (PA) PRESSURE AND HEART RATE IN NEW YORK HEART ASSOCIATION (NYHA) CLASS III HEART FAILURE PATIENTS WHO HAVE BEEN HOSPITALIZED FOR HEART FAILURE IN THE PREVIOUS YEAR. THE HEMODYNAMIC DATA ARE USED BY PHYSICIANS FOR HEART FAILURE MANAGEMENT AND WITH THE GOAL OF REDUCING HEART FAILURE HOSPITALIZATIONS.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Cardiovascular
- Decision date
- May 28, 2014
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P100045
- Regulatory pathway
- Premarket approval application
- Applicant
- ABBOTT MEDICAL
- Product code
- MOM
- Decision code
- APPR
- Decision date
- May 28, 2014
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, hemodynamic, implantable.
- Applicant
- Abbott Medical
- Product code
- MOM
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P100045 received
Application receipt date recorded by FDA.
P100045 · FDA decision
APPR
P100045/S092 · Related supplement
CardioMEMS PA Sensor and Delivery System (CM2000); CardioMEMS HF System
P100045/S091 · Related supplement
CardioMEMS HF System; Merlin.net PCN HF Portal (Model MN6000); CardioMEMS Backend Web Application (Model CM4000); HF Clo
P100045/S093 · Related supplement
CardioMEMS PA Sensor and Delivery System
Timeline entries are records held by MedtechLedger for P100045. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P100045
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ABBOTT MEDICAL | PMA supplement | Sep 11, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Sep 30, 2026 | FDA | |
CardioMEMS PA Sensor and Delivery SystemP100045/S093 | ABBOTT MEDICAL | PMA supplement | Sep 30, 2026 | FDA |
Explore the linked device profile
Other records with product code MOM
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Cordella Pulmonary Artery Sensor SystemP230040/S030 | Endotronix, Inc. | PMA supplement | Oct 29, 2026 | FDA |
| Endotronix, Inc. | PMA supplement | Oct 20, 2026 | FDA | |
| Endotronix, Inc. | PMA supplement | Oct 16, 2026 | FDA | |
| Endotronix, Inc. | PMA supplement | Oct 14, 2026 | FDA | |
| Endotronix, Inc. | PMA supplement | Sep 25, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Medical
- Headquarters
- Not reported
- Brand website
- abbott.com
- FDA applicant address
- 387 Nerem St. NW, Suite #500, Atlanta, GA, 30313
Sources and methodology
- Original FDA record: P100045
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




